Medicare Enrolled

Dr. Henry Hagenstein, D.O.

Optician · Grand Blanc, MI
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
3635 GENESYS PKWY, Grand Blanc, MI 48439
8106060682
In practice since 2006 (19 years)
NPI: 1346328226 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hagenstein from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hagenstein? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Hagenstein

Dr. Henry Hagenstein is an optician specialist in Grand Blanc, MI, with 19 years of NPI registration. Based on federal Medicare data, Dr. Hagenstein performed 740 Medicare services across 612 unique beneficiaries.

Between the years covered by Open Payments, Dr. Hagenstein received a total of $9,506 from 49 pharmaceutical and/or device companies across 787 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Hagenstein is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 44% volume in MI $9,506 industry payments

Medicare Practice Summary

Medicare Utilization ↗
740
Medicare services
Top 44% in MI for optician
612
Unique beneficiaries
$106
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~39 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
152 $68 $150
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
112 $59 $135
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
86 $106 $274
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
71 $76 $150
Nerve conduction studies, 11-12
A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies.
53 $186 $1,000
Assessment of and care planning for patient with impaired thought processing, typically 60 minutes 51 $181 $300
Awake and drowsy EEG
A test that records electrical activity in the brain while the patient is awake and drowsy.
44 $272 $625
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
36 $98 $250
New patient office visit, complex (60-74 min) 32 $141 $325
Balance testing with recording
A procedure to evaluate balance function by recording the results during testing.
22 $78 $180
Use of electrodes during balance testing
Application of electrodes to monitor physiological responses during a balance assessment.
22 $8 $30
Nerve conduction study, 9-10 studies
A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function.
18 $147 $1,000
Nerve conduction studies, 7-8 tests
A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles.
16 $125 $800
Vestibular function test using rotating chair
This test evaluates eye movement and balance function by having the patient sit in a rotating chair. It helps assess how the inner ear and brain coordinate to maintain stability.
13 $90 $150
Vestibular function test with thermal irrigation
A test that assesses balance by irrigating both ears with warm and cool fluids to evaluate inner ear function.
12 $28 $70
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$9,506
Total received (2018-2024)
Avg $1,358/year across 7 years
Top 10% in MI for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
787
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,350 (98.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$156 (1.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,551
2023
$1,429
2022
$1,187
2021
$1,167
2020
$1,138
2019
$1,846
2018
$1,189

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$329
EMD Serono, Inc.
$291
ABBVIE INC.
$211
CATALYST PHARMACEUTICALS, INC.
$79
Supernus Pharmaceuticals, Inc.
$72
Otsuka America Pharmaceutical, Inc.
$68
Novartis Pharmaceuticals Corporation
$55
Genentech USA, Inc.
$54
Eisai Inc.
$52
Teva Pharmaceuticals USA, Inc.
$49
JAZZ PHARMACEUTICALS INC.
$47
Acorda Therapeutics, Inc
$42
Lilly USA, LLC
$38
Neurelis, Inc.
$34
Neurocrine Biosciences, Inc.
$34
PFIZER INC.
$31
Avadel CNS Pharmaceuticals, LLC
$25
Celgene Corporation
$14
ARGENX US, INC.
$13
Amneal Pharmaceuticals LLC
$13
Top 3 companies account for 53.6% of 2024 payments
All-time payments by company (2018-2024) ›
Biogen, Inc.
$1,852
UCB, Inc.
$1,150
EMD Serono, Inc.
$761
ABBVIE INC.
$753
Novartis Pharmaceuticals Corporation
$631
Teva Pharmaceuticals USA, Inc.
$484
Supernus Pharmaceuticals, Inc.
$420
Genentech USA, Inc.
$302
NOVARTIS PHARMACEUTICALS CORPORATION
$217
GENZYME CORPORATION
$189
Allergan, Inc.
$171
Eisai Inc.
$167
Celgene Corporation
$161
Alexion Pharmaceuticals, Inc.
$134
Acorda Therapeutics, Inc
$131
ACADIA Pharmaceuticals Inc
$121
Amgen Inc.
$117
Lilly USA, LLC
$107
Otsuka America Pharmaceutical, Inc.
$106
Kyowa Kirin, Inc.
$102
SK Life Science, Inc.
$91
Neurelis, Inc.
$89
Lundbeck LLC
$88
Avanir Pharmaceuticals, Inc.
$81
CATALYST PHARMACEUTICALS, INC.
$79
Adamas Pharmaceuticals, Inc.
$78
Amneal Pharmaceuticals LLC
$78
Corium, LLC
$77
Janssen Pharmaceuticals, Inc
$67
Neurocrine Biosciences, Inc.
$63
Biohaven Pharmaceuticals, Inc.
$61
JAZZ PHARMACEUTICALS INC.
$60
PFIZER INC.
$54
US WorldMeds, LLC
$52
Allergan Inc.
$52
EISAI INC.
$51
Biohaven Pharmaceutical Holding Company Ltd.
$50
ARGENX US, INC.
$41
Sunovion Pharmaceuticals Inc.
$37
Takeda Pharmaceuticals U.S.A., Inc.
$28
Catalyst Pharmaceuticals, Inc.
$28
Avadel CNS Pharmaceuticals, LLC
$25
E.R. Squibb & Sons, L.L.C.
$18
Horizon Therapeutics plc
$17
Impax Laboratories, Inc.
$15
Zyla Life Sciences, Inc.
$14
Currax Pharmaceuticals LLC
$13
AbbVie Inc.
$13
Assertio Therapeutics, Inc.
$11
Top 3 companies account for 39.6% of all-time payments
Associated products mentioned in payments ›
ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Austedo XR · BOTOX · BOTOX THERAPEUTIC · Briviact · CAMBIA · COPAXONE · CREXONT · EMGALITY · EPIDIOLEX · Enspryng · FIRDAPSE · FYCOMPA · Fintepla · Fycompa · GAMMAGARD · GOCOVRI · INBRIJA · INGREZZA · KESIMPTA · LUMRYZ · LYRICA · Leqembi · MAVENCLAD · MAYZENT · Mavenclad · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · OCREVUS · ONGENTYS · ONZETRA XSAIL · OXTELLAR XR · Ocrevus · Ponvory · QULIPTA · Qelbree · REXULTI · RYTARY · Rebif · Rystiggo · SOLIRIS · SPRIX · Soliris · TECFIDERA · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · UZEDY · VALTOCO · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · XCOPRI · Xadago · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for optician in MI.

Looking for an optician specialist in Grand Blanc?
Compare opticians in the Grand Blanc area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
67
Per 100K population
16.6
County median income
$60,673
Nearest hospital
ASCENSION GENESYS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Hagenstein is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 10% of MI peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Hagenstein experienced with electromyography of arm or leg muscles?
Based on Medicare claims data, Dr. Hagenstein performed 152 electromyography of arm or leg muscles services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hagenstein receive payments from pharmaceutical companies?
Yes. Dr. Hagenstein received a total of $9,506 from 49 companies across 787 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hagenstein's costs compare to other opticians in Grand Blanc?
Dr. Hagenstein's average Medicare payment per service is $106. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hagenstein) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →